ENSG Earnings

ENSG reported its FY2025Q3 earnings on 2025-11-03, showcasing a revenue of 1.30B against an estimate of 1.28B, resulting in a 1.33% surprise. The EPS was 1.64, surpassing the expected 1.45 by 13.1%. The stock experienced a 0.05% price change on the earnings day and a -2.13% change over the next five days, reflecting market reactions to the results.

Following ENSG's FY2025Q3 earnings announcement on 2025-11-03, the stock price moved by 0.05% on the day of the release. Over the subsequent five days, it saw a -2.13% change. Historically, ENSG's stock price tends to shift by an average of -0.61% in the 10 days leading up to earnings and 2.18% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate ENSG's annual revenue to reach 1.37B, while the EPS is projected at 1.75. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between ENSG's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, ENSG's stock price typically moves by -0.61% in the 10 days before its earnings and 2.18% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of 1.75 and revenue of 1.37B.

The earnings call highlights robust financial performance with significant EPS and revenue growth, optimistic guidance, and strategic acquisitions. The company has a disciplined M&A approach and is effectively addressing labor challenges. The Q&A reveals confidence in Medicare program adaptation and occupancy growth. A dividend increase and strong cash flow further bolster sentiment. Overall, the positive financial metrics, strategic initiatives, and market positioning suggest a strong positive outlook for the stock.